Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Milestone Scientific ( (MLSS) ).
Milestone Scientific Inc. held its 2024 Annual Meeting of Stockholders on December 18, 2025, with 61.53% of its 78,628,913 outstanding common shares represented in the vote. Shareholders re-elected six incumbent directors, approved an increase in authorized common shares from 100 million to 125 million, and ratified CBIZCPA P.C. as the independent auditors for the fiscal year ending December 31, 2025, underscoring strong shareholder support for current leadership, expanded capital flexibility, and the company’s chosen auditing firm.
The most recent analyst rating on (MLSS) stock is a Hold with a $0.33 price target. To see the full list of analyst forecasts on Milestone Scientific stock, see the MLSS Stock Forecast page.
Spark’s Take on MLSS Stock
According to Spark, TipRanks’ AI Analyst, MLSS is a Neutral.
Milestone Scientific’s overall stock score is primarily impacted by its poor financial performance, including negative profitability and cash flow issues. The technical analysis and valuation also reflect challenges, while the earnings call provided some positive sentiment. However, the non-compliance notice from NYSE adds significant risk.
To see Spark’s full report on MLSS stock, click here.
More about Milestone Scientific
Average Trading Volume: 1,167,166
Technical Sentiment Signal: Sell
Current Market Cap: $25.18M
See more insights into MLSS stock on TipRanks’ Stock Analysis page.